August 2020 - Volume 42 - Issue 4 : Therapeutic Drug Monitoring

Secondary Logo

Journal Logo

August 2020 - Volume 42 - Issue 4
pp: 515-654

Therapeutic Drug Monitoring in Oncology

Is Salivary Busulfan the Cause of Oral Mucositis and the Changes in Salivary Antioxidant Enzymes After Hematopoietic Cell Transplantation?

de Paula Eduardo, Fernanda; Bezinelli, Letícia Mello; Carvalho, Danielle L. C.; More

Therapeutic Drug Monitoring. 42(4):565-571, August 2020.

Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis

Zhang, Ying; Wang, Taotao; Zhang, Di; More

Therapeutic Drug Monitoring. 42(4):600-609, August 2020.

A Retrospective Analysis of Steady-State Olanzapine Concentrations in Chinese Patients Using Therapeutic Drug Monitoring: Effects of Valproate and Other Factors

Deng, Shu-hua; Wang, Zhan-Zhang; Lu, Hao-Yang; More

Therapeutic Drug Monitoring. 42(4):636-642, August 2020.